Serum Institute delays expected launch of Novavax vaccine in India

The launch in India of a new COVID-19 vaccine developed jointly by the Serum Institute of India and U.S.-based biotech firm Novavax (NVAX.O) is likely to be delayed to September, the Indian company’s boss said on Saturday. Adar Poonawalla, the chief executive of Serum, said in January that the vaccine, […]